Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Monitoring Power Supply Stability – V 2.0

Posted on By


Biosimilars: SOP for Monitoring Power Supply Stability – V 2.0


Standard Operating Procedure for Monitoring Power Supply Stability in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/123/2025
Supersedes SOP/BS/123/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define a standardized procedure for monitoring power supply stability in the biosimilar upstream manufacturing area to prevent equipment malfunction, ensure continuous operations, and comply with GMP infrastructure requirements.

2. Scope

This SOP applies to all power-dependent systems including bioreactors, incubators, centrifuges, HVAC, SCADA, and cold storage equipment used in biosimilar manufacturing facilities.

3. Responsibilities

  • Engineering Department: Perform routine checks on voltage, phase, and UPS function. Maintain logs.
  • Production: Notify Engineering and QA of any power-related abnormalities.
  • QA: Review and verify power stability records as part of facility qualification and batch release.

4. Accountability

The Head of Engineering is accountable for ensuring uninterrupted, regulated power supply to all critical biosimilar equipment and for reporting any power anomalies to QA and Site Management.

5. Procedure

5.1 Monitoring Parameters and Frequency

  1. Monitor and record the following at defined frequencies:
    • Voltage Stability (230V ± 5%) – Daily
    • Frequency Stability (50 Hz ± 0.5 Hz) – Weekly
    • UPS Battery Voltage and Load – Weekly
    • Generator and Switchgear Function – Monthly

5.2 Equipment and Tools Used

  1. Digital Power Analyzer with data logger
  2. UPS monitoring software
  3. Manual voltmeters for cross-checks

5.3 Logging and Reporting

  1. Record daily voltage and frequency values in Annexure-1: Power Monitoring Log.
  2. Log UPS diagnostic reports weekly in Annexure-2.
  3. Any deviation from acceptable limits must be escalated immediately to Site Head and QA.

5.4 Action in Case of Power Instability

  1. If fluctuations exceed limits:
    • Isolate affected equipment immediately.
    • Switch to backup power or stabilize via UPS.
    • Document incident in Annexure-3 and initiate deviation report.
  2. Engineering must perform root cause analysis within 24 hours.

5.5 Preventive Measures

  1. Schedule quarterly maintenance of power panels and UPS units.
  2. Maintain clean electrical panels and cable routing.
  3. Ensure 24×7 auto-alarm notifications are enabled for UPS and generators.

6. Abbreviations

  • UPS: Uninterruptible Power Supply
  • Hz: Hertz
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. Power Monitoring Log – Annexure-1
  2. UPS Performance Log – Annexure-2
  3. Power Deviation Report – Annexure-3

8. References

  • WHO Annex 5: GMP for HVAC and Power Infrastructure
  • ICH Q9 – Quality Risk Management
  • IS 732 – Code of Practice for Electrical Wiring Installations

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Power Monitoring Log

Date Voltage (V) Frequency (Hz) Logged By Remarks
04/05/2025 229.5 49.9 Sunita Reddy Within range

Annexure-2: UPS Performance Log

Date Battery Voltage Load % Backup Time Tested By
02/05/2025 230V 45% 40 mins Ajay Verma

Annexure-3: Power Deviation Report

Date Incident Action Taken Root Cause Preventive Measure
01/05/2025 Voltage Drop Switched to UPS External Grid Dip Installed AVR

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added UPS log and deviation reporting process Audit recommendation
See also  Biosimilars: SOP for Agitation and Aeration Monitoring in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Sealing Gel Packaging to Prevent Contamination – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Weight Variation Testing of Injectable Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version